A decade in banking Ewing sarcoma

A report from the Children's Oncology Group

Scott C. Borinstein, Natalie Beeler, John J. Block, Richard Gorlick, Patrick Grohar, Paul Jedlicka, Mark Krailo, Carol Morris, Sharon Phillips, Gene P. Siegal, Elizabeth R. Lawlor, Stephen L. Lessnick

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Outcomes for patients with metastatic and recurrent Ewing sarcoma remain poor and a better understanding of the biology of this malignancy is critical to the development of prognostic biomarkers and novel therapies. Therefore, the Children's Oncology Group (COG) has created tissue banking protocols designed to collect high quality, clinically annotated, tumor specimens that can be distributed to researchers to perform basic science and correlative investigation. Data from the COG Ewing sarcoma tissue banking protocols AEWS02B1 and its successor study AEWS07B1 were reviewed in this study. Six-hundred and thirty five patients were enrolled on AEWS02B1 and 396 patients have had tissue submitted to AEWS07B1. The average age of participation was 13.2 years. About 86% were less than 19 years old and only 6% were greater than 21 years of age at diagnosis. When compared to SEER data, approximately 18% of all cases and only 8% of all patients >20 years old diagnosed with Ewing sarcoma annually in the United States have had tumor banked. The majority of participants submitted formalin fixed, paraffin embedded, primary tumor and blood samples. In total, fresh frozen tissue was submitted for only 29% of cases. Only seven metastatic tumor samples have been collected. Although the COG has been successful in collecting tumor samples from patients newly diagnosed with Ewing sarcoma, fresh frozen tumor specimens from primary and metastatic disease are critically needed, especially from young adult patients, in order to conduct high quality basic science and translational research investigation with a goal of developing better treatments.

Original languageEnglish (US)
Article numberArticle 00057
JournalFrontiers in Oncology
Volume3 MAR
DOIs
StatePublished - 2013

Fingerprint

Ewing's Sarcoma
Neoplasms
Tissue Banks
Translational Medical Research
Paraffin
Formaldehyde
Young Adult
Biomarkers
Research Personnel
Therapeutics

Keywords

  • Adolescent and young adult
  • Biopsy
  • Bone tumor
  • Ewing sarcoma
  • Interventional radiology
  • Tumor banking

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Borinstein, S. C., Beeler, N., Block, J. J., Gorlick, R., Grohar, P., Jedlicka, P., ... Lessnick, S. L. (2013). A decade in banking Ewing sarcoma: A report from the Children's Oncology Group. Frontiers in Oncology, 3 MAR, [Article 00057]. https://doi.org/10.3389/fonc.2013.00057

A decade in banking Ewing sarcoma : A report from the Children's Oncology Group. / Borinstein, Scott C.; Beeler, Natalie; Block, John J.; Gorlick, Richard; Grohar, Patrick; Jedlicka, Paul; Krailo, Mark; Morris, Carol; Phillips, Sharon; Siegal, Gene P.; Lawlor, Elizabeth R.; Lessnick, Stephen L.

In: Frontiers in Oncology, Vol. 3 MAR, Article 00057, 2013.

Research output: Contribution to journalArticle

Borinstein, SC, Beeler, N, Block, JJ, Gorlick, R, Grohar, P, Jedlicka, P, Krailo, M, Morris, C, Phillips, S, Siegal, GP, Lawlor, ER & Lessnick, SL 2013, 'A decade in banking Ewing sarcoma: A report from the Children's Oncology Group', Frontiers in Oncology, vol. 3 MAR, Article 00057. https://doi.org/10.3389/fonc.2013.00057
Borinstein SC, Beeler N, Block JJ, Gorlick R, Grohar P, Jedlicka P et al. A decade in banking Ewing sarcoma: A report from the Children's Oncology Group. Frontiers in Oncology. 2013;3 MAR. Article 00057. https://doi.org/10.3389/fonc.2013.00057
Borinstein, Scott C. ; Beeler, Natalie ; Block, John J. ; Gorlick, Richard ; Grohar, Patrick ; Jedlicka, Paul ; Krailo, Mark ; Morris, Carol ; Phillips, Sharon ; Siegal, Gene P. ; Lawlor, Elizabeth R. ; Lessnick, Stephen L. / A decade in banking Ewing sarcoma : A report from the Children's Oncology Group. In: Frontiers in Oncology. 2013 ; Vol. 3 MAR.
@article{1c416c2341d54301bccdb7cbc1898917,
title = "A decade in banking Ewing sarcoma: A report from the Children's Oncology Group",
abstract = "Outcomes for patients with metastatic and recurrent Ewing sarcoma remain poor and a better understanding of the biology of this malignancy is critical to the development of prognostic biomarkers and novel therapies. Therefore, the Children's Oncology Group (COG) has created tissue banking protocols designed to collect high quality, clinically annotated, tumor specimens that can be distributed to researchers to perform basic science and correlative investigation. Data from the COG Ewing sarcoma tissue banking protocols AEWS02B1 and its successor study AEWS07B1 were reviewed in this study. Six-hundred and thirty five patients were enrolled on AEWS02B1 and 396 patients have had tissue submitted to AEWS07B1. The average age of participation was 13.2 years. About 86{\%} were less than 19 years old and only 6{\%} were greater than 21 years of age at diagnosis. When compared to SEER data, approximately 18{\%} of all cases and only 8{\%} of all patients >20 years old diagnosed with Ewing sarcoma annually in the United States have had tumor banked. The majority of participants submitted formalin fixed, paraffin embedded, primary tumor and blood samples. In total, fresh frozen tissue was submitted for only 29{\%} of cases. Only seven metastatic tumor samples have been collected. Although the COG has been successful in collecting tumor samples from patients newly diagnosed with Ewing sarcoma, fresh frozen tumor specimens from primary and metastatic disease are critically needed, especially from young adult patients, in order to conduct high quality basic science and translational research investigation with a goal of developing better treatments.",
keywords = "Adolescent and young adult, Biopsy, Bone tumor, Ewing sarcoma, Interventional radiology, Tumor banking",
author = "Borinstein, {Scott C.} and Natalie Beeler and Block, {John J.} and Richard Gorlick and Patrick Grohar and Paul Jedlicka and Mark Krailo and Carol Morris and Sharon Phillips and Siegal, {Gene P.} and Lawlor, {Elizabeth R.} and Lessnick, {Stephen L.}",
year = "2013",
doi = "10.3389/fonc.2013.00057",
language = "English (US)",
volume = "3 MAR",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - A decade in banking Ewing sarcoma

T2 - A report from the Children's Oncology Group

AU - Borinstein, Scott C.

AU - Beeler, Natalie

AU - Block, John J.

AU - Gorlick, Richard

AU - Grohar, Patrick

AU - Jedlicka, Paul

AU - Krailo, Mark

AU - Morris, Carol

AU - Phillips, Sharon

AU - Siegal, Gene P.

AU - Lawlor, Elizabeth R.

AU - Lessnick, Stephen L.

PY - 2013

Y1 - 2013

N2 - Outcomes for patients with metastatic and recurrent Ewing sarcoma remain poor and a better understanding of the biology of this malignancy is critical to the development of prognostic biomarkers and novel therapies. Therefore, the Children's Oncology Group (COG) has created tissue banking protocols designed to collect high quality, clinically annotated, tumor specimens that can be distributed to researchers to perform basic science and correlative investigation. Data from the COG Ewing sarcoma tissue banking protocols AEWS02B1 and its successor study AEWS07B1 were reviewed in this study. Six-hundred and thirty five patients were enrolled on AEWS02B1 and 396 patients have had tissue submitted to AEWS07B1. The average age of participation was 13.2 years. About 86% were less than 19 years old and only 6% were greater than 21 years of age at diagnosis. When compared to SEER data, approximately 18% of all cases and only 8% of all patients >20 years old diagnosed with Ewing sarcoma annually in the United States have had tumor banked. The majority of participants submitted formalin fixed, paraffin embedded, primary tumor and blood samples. In total, fresh frozen tissue was submitted for only 29% of cases. Only seven metastatic tumor samples have been collected. Although the COG has been successful in collecting tumor samples from patients newly diagnosed with Ewing sarcoma, fresh frozen tumor specimens from primary and metastatic disease are critically needed, especially from young adult patients, in order to conduct high quality basic science and translational research investigation with a goal of developing better treatments.

AB - Outcomes for patients with metastatic and recurrent Ewing sarcoma remain poor and a better understanding of the biology of this malignancy is critical to the development of prognostic biomarkers and novel therapies. Therefore, the Children's Oncology Group (COG) has created tissue banking protocols designed to collect high quality, clinically annotated, tumor specimens that can be distributed to researchers to perform basic science and correlative investigation. Data from the COG Ewing sarcoma tissue banking protocols AEWS02B1 and its successor study AEWS07B1 were reviewed in this study. Six-hundred and thirty five patients were enrolled on AEWS02B1 and 396 patients have had tissue submitted to AEWS07B1. The average age of participation was 13.2 years. About 86% were less than 19 years old and only 6% were greater than 21 years of age at diagnosis. When compared to SEER data, approximately 18% of all cases and only 8% of all patients >20 years old diagnosed with Ewing sarcoma annually in the United States have had tumor banked. The majority of participants submitted formalin fixed, paraffin embedded, primary tumor and blood samples. In total, fresh frozen tissue was submitted for only 29% of cases. Only seven metastatic tumor samples have been collected. Although the COG has been successful in collecting tumor samples from patients newly diagnosed with Ewing sarcoma, fresh frozen tumor specimens from primary and metastatic disease are critically needed, especially from young adult patients, in order to conduct high quality basic science and translational research investigation with a goal of developing better treatments.

KW - Adolescent and young adult

KW - Biopsy

KW - Bone tumor

KW - Ewing sarcoma

KW - Interventional radiology

KW - Tumor banking

UR - http://www.scopus.com/inward/record.url?scp=84890661068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890661068&partnerID=8YFLogxK

U2 - 10.3389/fonc.2013.00057

DO - 10.3389/fonc.2013.00057

M3 - Article

VL - 3 MAR

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

M1 - Article 00057

ER -